coli and K
59 Small molecule GLP-1RA in preclinical trials MLX-7005 MLX-7005 is a highly potent, oral small-molecule GLP-1 receptor agonist (GLP-1RA) that robustly activates the GLP-1 receptor cAMP signaling pathway without measurable -arrestin recruitment
The applicant asserted that the Axoguard HA+ Nerve Protector TM demonstrates clinical improvement in: (1) nerve health in an injured tissue bed through less adhesion, extraneural scarring, and inflammatory markers, (2) nerve health in an injured tissue bed through decreased friction between the nerve and surrounding tissue to allow for gliding and to minimize potential for soft tissue attachment, (3) device performance due to its sodium hyaluronate and sodium alginate gel layer that allows for nerve gliding, and (4) sensory and motor symptoms
Water, Glycerin, 1,2-Hexanediol, Glutathione, Glycyrrhiza Glabra (Licorice) Root Extract, Magnesium Ascorbyl Phosphate, Polyglutamic Acid, Ceramide NP, Astragalus Membranaceus Root Extract, Schisandra Chinensis Fruit Water, Butylene Glycol, Hydrogenated Lecithin, Allantoin, Tocopherol, Sodium Citrate, Sodium Phytate, Citric Acid, Polyglyceryl-10 Laurate, Ethylhexylglycerin
Kang TH, Friedmann T
Eur J Nutr 61(3):15071520
